Breaking news

Amazon SAS Advances €4 Million Pharmaceutical Facility in Limassol

Amazon SAS has received the green light from the Environmental Authority to construct a state-of-the-art pharmaceutical manufacturing plant in Limassol, Cyprus. This ambitious €4 million project is set to be situated in the industrious Pentakomo-Monagroulli zone, precisely 620 meters southeast of Monagroulli village.

The construction timeline, as per the environmental impact assessment from September 2024, anticipates around ten months for completion, subject to any unexpected hurdles.

Details of the Facility

The expansive factory will cover 4,405 square meters over three levels. The underground level is designated for parking and auxiliary spaces, the second level will host pharmaceutical production, while the third level will accommodate offices and further auxiliary areas.

Notably, the plant will focus on solid pharmaceutical products like tablets and capsules, aiming for an annual output of 40 to 50 million units. Packaging will be diversified between bottles and blister packs, projecting an annual volume of approximately 10 million packaging units.

Infrastructure and Accessibility

The plant’s infrastructure includes multiple access points, with a controlled vehicle entrance, loading bay, and dedicated green spaces. A total of 50 parking spaces will cater to employees and visitors, ensuring accessibility options. The site will adhere strictly to health, safety, and environmental protocols in alignment with Cypriot and EU standards.

Strategic Significance

This development signifies a significant boost to the local economy, potentially paving the way for further industrial advancements in the region. For insights into how this project fits into broader economic trends, consider exploring Cyprus Housing Market Slows Amid Rising Costs and Regional Divergence.

Copyright Law Struggles To Keep Up With AI Training

Courts Are Still Applying Old Copyright Rules To AI

AI companies train models on enormous amounts of published material, including books, articles and academic research. Whether using that content without authors’ permission violates copyright law remains unresolved.

Much of the debate centres on fair use, which allows copyrighted material to be used without permission in certain circumstances. Courts consider factors such as the purpose of the use, how much material was involved and its impact on the original market.

Anthropic Case Sets An Important Precedent

A major case involving Anthropic and a group of authors provided one of the clearest rulings so far. Judge William Alsup found that using copyrighted books to train AI models was lawful, comparing the process to people reading and studying literature before creating something new.

Anthropic was nevertheless ordered to pay $1.5 billion in a settlement. The penalty concerned books the company had obtained from illegal online libraries rather than the AI training itself.

For AI companies, that distinction could prove significant because it separates studying copyrighted material from directly copying it.

Competition Could Be The Key Issue

A case involving Thomson Reuters and Ross Intelligence offers a different perspective. A court ruled that Ross could not claim fair use after using Reuters’ copyrighted material to develop a competing AI-powered legal research platform.

The decision suggests courts may be less willing to consider AI training fair use when copyrighted content is used to build a product that directly competes with the original.

For authors, an unresolved question is whether AI-generated content should be considered competition for the works used to train these models.

The Law Has Yet To Catch Up

US copyright law predates generative AI by decades, leaving courts to apply old principles to new technology. Questions also remain over copyright protection for AI-generated works. In Thaler v. Perlmutter, a court ruled that material created entirely by AI cannot receive copyright protection.

Major AI companies remain involved in copyright litigation, and different courts could reach different conclusions. For now, there is no universal rule: the legality of AI training will depend on the circumstances of each case and how courts ultimately interpret copyright and fair use.

Uol
Aretilaw firm
The Future Forbes Realty Global Properties
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter